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Oral adsorbent ameliorates renal TGF-b1 expression in hyper- nemia. Thus, the Imai rats are considered to be a model
cholesterolemic rats. of focal glomerulosclerosis with nephrotic syndrome, al-
Background. A spontaneously hypercholesterolemic Imai rat though abnormal lipid metabolism may accelerate the
has recently been reported as a model of focal glomerulosclero-
glomerular lesion.sis that causes nephrotic syndrome followed by renal failure.
Transforming growth factor (TGF)-b1 plays a centralThis study was designed to determine if an oral adsorbent,
AST-120, ameliorates renal lesions and TGF-b1 expression in role in the progression of renal fibrosis [6]. TGF-b1 in-
the rats. creases the production of extracellular matrix such as
Methods. AST-120 was given orally to the Imai rats for 32 collagen, and decreases matrix degradation by down-
weeks, and renal function and pathology were compared be- regulating the synthesis of matrix-degrading metallopro-tween the AST-120-administered and control Imai rats.
teinases (MMP) and up-regulating the synthesis of MMPResults. AST-120-administered rats showed significantly
inhibitors such as tissue inhibitor of metalloproteinaselower levels of blood urea nitrogen, serum creatinine, urinary
protein, serum total-cholesterol, serum triglyceride, and serum (TIMP)-1. Infiltrating macrophages also play an important
and urinary indoxyl sulfate, and significantly higher levels of role in renal fibrogenesis by secreting TGF-b1 [6]. This
serum albumin and creatinine clearance than control rats. AST- study was designed to determine if AST-120 ameliorates
120 reduced the glomerular sclerosis index, interstitial fibrosis
renal lesions and TGF-b1 expression in the Imai rats.area, and the extent of glomerular lipid deposition. Immunohis-
tochemistry demonstrated that AST-120 reduced the expres-
sion of transforming growth factor (TGF)-b1 and tissue inhibitor METHODSof metalloproteinase (TIMP)-1 as well as interstitial infiltration
Experimental designof macrophages in the renal cortex of the Imai rats.
Conclusions. AST-120 prevented the progression of ne- Ten male Imai rats were obtained from Takeda Phar-
phrotic syndrome and renal failure in the Imai rats by amelio-
maceutical Co., Osaka, Japan. These rats at 10 weeks ofrating glomerular sclerosis and interstitial fibrosis, accompa-
age were divided into two groups: the control groupnied with reduced expression of TGF-b1 and TIMP-1, and
(N 5 5) and the AST-120 group (N 5 5). Both groupsreduced infiltration of macrophages in the kidneys.
were fed with standard solid rat chow (CE-2; Clea, Ja-
pan) containing 24.8% protein. AST-120 group rats were
fed with the diet containing 5% AST-120. Table 1 showsCirculating uremic toxins are thought to be involved
the net dietary intake and net protein intake. After thein the progression of chronic renal failure [1–4]. An
administration of AST-120 for 32 weeks, the rats wereoral adsorbent, AST-120, is effective in removing uremic
sacrificed, and their renal tissues were obtained.toxins such as indoxyl sulfate by intestinal absorption of
the uremic toxins or their precursors (indole, etc.), and Biochemical studies
delays the progression of chronic renal failure in uremic
Blood urea nitrogen, serum creatinine, urinary pro-rats [1, 3].
tein, creatinine clearance, and serum and urinary indoxylSpontaneously hypercholesterolemic Imai rats [5],
sulfate were measured according to the methods de-originally derived from Sprague-Dawley rats, develop
scribed previously [1]. Serum total cholesterol and tri-focal glomerulosclerosis and consequent renal failure,
glyceride were measured using a lipid analyzer SP-4410accompanied with massive proteinuria and hypoalbumi-
(Kyoto Daiichi Kagaku, Kyoto, Japan).
Pathological studiesKey words: AST-120, focal glomerulosclerosis, transforming growth
factor-b, hyperlipidemia, progressive renal disease. Kidney weights were measured at autopsy, and then
light microscopic studies were performed. All sections 1999 by the International Society of Nephrology
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Table 1. Time course of biochemical and pathological parameters in AST-120-administered and control Imai rats
Control group AST-120 group
Week 0 10 20 32 0 10 20 32
Biochemical data
Dietary intake, g/day 23.160.4 25.0 60.0 23.5 60.9 17.6 60.7 23.2 60.4 25.0 60.0 24.3 60.3 24.3 60.4c
Protein intake, g/day 5.760.1 6.2 60.0 5.8 60.2 4.4 60.2 5.7 60.1 6.2 60.0 6.0 60.1 6.0 60.1c
Body weight, g 39267 496 66 546 611 495 611 392 65 477 64a 52964 549 68b
Blood urea nitrogen, mg/dl 1761 15 61 33 69 73 62 16 61 13 61 20 61 24 61c
Serum creatinine, mg/dl 0.460.0 0.6 60.0 0.5 60.1 2.0 60.1 0.4 60.0 0.5 60.0 0.4 60.0a 0.760.0c
Urinary protein, mg/day 6069 110616 236 637 379 650 51 67 77 611 139613a 201618a
Creatinine clearance, ml/min 2.0660.08 1.82 60.13 2.26 60.20 0.62 60.05 1.99 60.19 1.78 60.12 2.70 60.24 1.56 60.08c
Serum total-cholesterol, mg/dl 8164 191613 312 644 491 632 77 63 14669 192 612a 248632b
Serum triglyceride, mg/dl 10966 211 618 364 632 429 642 113 612 114 618b 249632a 248613b
Serum albumin, mg/dl 3.960.1 3.8 60.1 3.2 60.2 2.7 60.0 4.1 60.1 4.0 60.1 3.6 60.1d 3.360.1b
Serum indoxyl sulfate, mg/dl 0.1660.02 0.10 60.01 0.10 60.02 0.22 60.02 0.18 60.01 0.01 60.00c 0.0160.00c 0.0260.0c
Urinary indoxyl sulfate,
mg/day 2.1360.20 2.12 60.10 1.94 60.16 2.13 60.31 2.23 60.21 0.26 60.02c 0.4660.08c 0.4960.05c
Pathological data
Kidney weight (right 1 left), g 7.5760.35 5.73 60.24b
Glomerular volume, 31023 mm3 3.5760.39 2.83 60.20d
Glomerular sclerosis index 2.35 60.10 1.09 60.13c
Interstitial fibrosis area, % 13.961.7 8.2 61.2a
Sudan III-stained area per
glomerulus, % 3.560.7 0.5 60.2b
Immunohistochemical data
TGF-b1-positive cells per
glomerulus 12.061.2 7.7 60.5a
TGF-b1-stained tubulointer-
stitial area, % 1.2260.14 0.72 60.10a
TIMP-1-positive cells, /hpf
(tubulointerstitium) 4.360.5 2.0 60.2b
ED-1-positive cells, /hpf
(tubulointerstitium) 6.060.6 2.7 60.2b
Data are shown as mean 6 se.
The abbreviation hpf is high power field.
a P , 0.05, b P , 0.01, c P , 0.001, d P , 0.1 vs. control group at the same age by Student’s t-test
were stained with periodic acid-Schiff (PAS), Masson’s and a monoclonal anti-rat macrophage antibody (ED-1;
trichrome, and Sudan III. Glomerular planar area was Serotec, Oxford, UK) [6].
measured by using an image analysis system LA-555 TGF-b1-positive cells per glomerulus were counted in
(Pias, Tokyo, Japan), and then glomerular volume was 20 glomeruli selected randomly from a section of renal
calculated according to the method of Wiebel and Go- cortex [6]. TGF-b1-stained tubulointerstitial area was
mez, which was assessed by Lane, Steffes and Mauer measured by using the image analyzer V10LAB. TIMP-1-
[7]. A semiquantitative score was used in PAS-stained positive cells and ED-1-positive cells were counted in
sections to evaluate the extent of glomerular sclerosis ten randomly chosen tubulointerstitial fields (3400 mag-
according to the method of Raij, Azar and Keane [8]. nification) in a section of renal cortex.
Interstitial fibrosis area was measured in Masson’s tri-
Statistical analysischrome-stained sections by using an image analyzer
V10LAB (Toyo Boseki, Tokyo, Japan). Sudan III- Results are expressed as mean 6 se. Student’s t-test
stained area per glomerulus was measured by using the was performed to compare the two groups. The correla-
image analyzer V10LAB. tions among biochemical and pathological parameters
in all rats were determined using linear regression analy-
Immunohistochemical studies sis. A P value less than 0.05 was considered statistically
significant.Immunostaining of TGF-b1, TIMP-1, and ED-1 in
renal tissue sections was conducted using the streptavi-
din-biotinylated peroxidase complex (SABC) method.
RESULTS
The primary antibodies used in this study were a chicken
Biochemical studiespolyclonal anti-human TGF-b1 antibody (R&D Sys-
tems, Minneapolis, MN, USA), a monoclonal anti- AST-120-administered rats showed significantly lower
levels of blood urea nitrogen, serum creatinine, urinaryhuman TIMP-1 antibody (kind gift from Prof. Saga) [9],
Fig. 1. Light micrographs of PAS-staining (A,B), Sudan III-staining (C,D), TGF-b1-immunostaining (E,F), TIMP-1-immunostaining (G), and
ED-1-immunostaining (H) in the renal cortices of a control Imai rat (A, C, E, G, H) and an AST-120-administered Imai rat (B, D, F) (A, B, C,
D, 3100; E, F, 3200; G, H, 3400).
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protein, serum total-cholesterol, serum triglyceride, and These TGF-b1-positive cells were mainly glomerular ep-
ithelial and mesangial cells. Because we studied only ratsserum and urinary indoxyl sulfate, and significantly
higher levels of serum albumin and creatinine clearance at 42 weeks of age, we cannot exclude the possibility
that macrophages infiltrate the rat glomeruli at a differ-than control rats (Table 1). Thus, AST-120 prevented
the progression of nephrotic syndrome and renal failure ent age.
AST-120 decreased the serum and urinary levels ofin the Imai rats.
indoxyl sulfate. We have recently reported that the ad-
Pathological and immunohistochemical studies ministration of indoxyl sulfate, a uremic toxin, up-regu-
lated the gene expression of TGF-b1, TIMP-1, and pro-Both groups showed glomerular and tubulointerstitial
lesions such as glomerular sclerosis, tubular dilation and a1(I) collagen in the kidneys of uremic rats [2, 4]. Thus,
some circulating uremic toxins such as indoxyl sulfate,atrophy, interstitial expansion, and interstitial cellular
infiltration (Fig. 1 A, B). However, the extent of these which are removed by AST-120 through intestinal ab-
sorption of the toxins or their precursors, may acceleratepathological changes in the AST-120 group was not so
severe as compared with control group. Sudan III stain- the progression of glomerular sclerosis and interstitial
fibrosis in the Imai rats.ing demonstrated that lipid deposition was detected only
in the glomeruli of both groups (Fig. 1 C, D). However, AST-120 reduced the serum levels of lipids and the
extent of glomerular lipid deposition in the Imai rats.the extent of glomerular lipid deposition was less marked
in the AST-120 group. Although AST-120 cannot absorb lipoproteins due to
their large molecule size, it can adsorb small moleculeImmunohistochemistry demonstrated that TGF-b1
was localized in glomerular (mainly epithelial and mes- lipids. However, its absorption capacity is not so large
to reduce serum lipid levels, because AST-120 adminis-angial cells), tubular and interstitial cells, especially in
the fibrotic lesions of both groups (Fig. 1 E, F). TIMP-1 tration for six months to normal rats did not significantly
change their serum total cholesterol and triglyceride lev-(Fig. 1G) and ED-1-positive cells (Fig. 1H) were de-
els. In the present study, AST-120 also decreased urinarytected only in the interstitial fibrotic lesions of both
protein and increased serum albumin. These data suggestgroups, but not in the glomerular lesions.
that AST-120 may have reduced the serum levels ofAs shown in Table 1, the AST-120 group showed sig-
lipids and the extent of glomerular lipid deposition innificantly lower levels of all pathological and immunohis-
the Imai rats, at least partly, by ameliorating nephrotictochemical parameters except glomerular volume in the
syndrome.control group. Furthermore, glomerular sclerosis showed
In conclusion, AST-120 ameliorated glomerular scle-significant correlations with TGF-b1-positive cells per
rosis and interstitial fibrosis with reduced expression ofglomerulus (r 5 0.78), Sudan III-stained area per glomer-
TGF-b1 and TIMP-1, and reduced infiltration of macro-ulus (r 5 0.70), and creatinine clearance (r 5 20.90).
phages in the kidneys of Imai rats.In addition, interstitial fibrosis area showed significant
correlations with TGF-b1-stained tubulointerstitial area
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